Assessing the Prognostic Significance of Interleukin-6, Neuropilin-1, and Amphiregulin Levels for Mortality Prediction in ICU Patients with Sepsis or Septic Shock - Scorecard - MDSpire
Advertisement
Assessing the Prognostic Significance of Interleukin-6, Neuropilin-1, and Amphiregulin Levels for Mortality Prediction in ICU Patients with Sepsis or Septic Shock
Clinical Scorecard: Assessing the Prognostic Significance of Interleukin-6, Neuropilin-1, and Amphiregulin Levels for Mortality Prediction in ICU Patients with Sepsis or Septic Shock
At a Glance
Category
Detail
Condition
Key Mechanisms
Target Population
Patients aged ≥ 18 years admitted to ICU with Sepsis-3 criteria for sepsis or septic shock.
Care Setting
Key Highlights
IL-6 levels correlate with poor prognosis and mortality in severe sepsis and septic shock.
Nrp-1 may provide adjunct prognostic information beyond established clinical risk scores.
AREG contributes to tissue defense and repair mechanisms during inflammation.
This study evaluates the association of IL-6, Nrp-1, and AREG levels with 28- and 90-day mortality.
Guideline-Based Recommendations
Diagnosis
Management
Monitoring & Follow-up
Monitor IL-6, Nrp-1, and AREG levels for prognosis in ICU patients within the first 24 hours.
Risks
Patient & Prescribing Data
Biomarkers may guide treatment decisions and prognostic evaluations, particularly in risk stratification.
Clinical Best Practices
Collect blood samples for biomarker analysis within 24 hours of ICU admission to ensure timely and accurate results.
Use a multi-biomarker approach for better prognostic accuracy.